$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Week 11/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD in week 11/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 944 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 7.16 | 944 | 6,762 | 0 | 944 to 0 (-100.00 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 944 | 0 | 944 | 0 to 944 |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 2,359 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 7.16 | 2,359 | 16,899 | 2,974 | 5.3 K to 3 K (-44.23 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 2,359 | 0 | 5,333 | 3 K to 5.3 K (+79.32 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 7.16 | 470 | 3,367 | 14,868 | 15.3 K to 14.9 K (-3.06 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,179 | 0 | 15,338 | 14.2 K to 15.3 K (+8.33 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 874 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 7.17 | 345 | 2,474 | 19,844 | 20.2 K to 19.8 K (-1.71 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 874 | 0 | 20,189 | 19.3 K to 20.2 K (+4.52 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 266 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 748 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 134 | 960 | 45,561 | 45.7 K to 45.6 K (-0.29 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 380 | 2,722 | 45,695 | 46.1 K to 45.7 K (-0.82 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 266 | 0 | 46,075 | 45.8 K to 46.1 K (+0.58 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 748 | 0 | 45,809 | 45.1 K to 45.8 K (+1.66 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,179 | 0 | 20,639 | 19.5 K to 20.6 K (+6.06 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 1,297 | 0 | 0 | |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 7.17 | 616 | 4,418 | 10,400 | 11 K to 10.4 K (-5.59 %) |
| Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 1,297 | 0 | 11,016 | 9.7 K to 11 K (+13.34 %) |